Aeglea Biotherapeutics shares owned by Citigroup
Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by Citigroup
from 13F filings
Historical chart of Citigroup investment in Aeglea Biotherapeutics
Tip: Access up to 7 years of quarterly data
All positions including Aeglea Biotherapeutics held by Citigroup consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Aeglea Biotherapeutics by Citigroup
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $606k | 12k | 50.44 |
| 2025-03-31 | $1.3M | 84k | 16.14 |
| 2024-12-31 | $1.7M | 74k | 23.28 |
| 2024-09-30 | $741k | 25k | 29.41 |
| 2024-06-30 | $454k | 19k | 23.51 |
| 2024-03-31 | $1.2M | 32k | 37.93 |
| 2023-12-31 | $222k | 10k | 21.52 |